detection of ctDNA mutations in plasma of colorectal cancer patients by PCR/SERS

Mastery Studying Ensures Right Private Protecting Gear Use in Simulated Medical Encounters of COVID-19

Introduction: The proper use of private protecting gear (PPE) limits transmission of significant communicable ailments to healthcare employees, which is critically necessary within the period of coronavirus illness 2019 (COVID-19). Nonetheless, prior research illustrated that healthcare employees often err throughout utility and elimination of PPE. The aim of this research was to find out whether or not a simulation-based, mastery studying intervention with deliberate observe improves appropriate use of PPE by physicians throughout a simulated medical encounter with a COVID-19 affected person.

Strategies: 

  • This was a pretest-posttest research carried out within the emergency division at a big, educational tertiary care hospital between March 31-April 8, 2020. A complete of 117 topics participated, together with 56 school members and 61 resident physicians. Previous to the intervention, all contributors acquired institution-mandated training on PPE use by way of a web based video and supplemental supplies.
  • Individuals accomplished a pretest abilities evaluation utilizing a 21-item guidelines of steps to appropriately don and doff PPE. Individuals had been anticipated to fulfill a minimal passing rating (MPS) of 100%, decided by an skilled panel utilizing the Mastery Angoff and Affected person Security standard-setting strategies. Individuals that met the MPS on pretest had been exempt from the tutorial intervention.
  • Testing occurred earlier than and after an in-person demonstration of correct donning and doffing strategies and 20 minutes of deliberate observe. The first end result was a change in evaluation scores of appropriate PPE use following our instructional intervention. Secondary outcomes included variations in efficiency scores between school members and resident physicians, and variations in efficiency throughout donning vs doffing sequences.

Outcomes: All contributors had a imply pretest rating of 73.1% (95% confidence interval [CI], 70.9-75.3%). College member and resident pretest scores had been related (75.1% vs 71.3%, p = 0.082). Imply pretest doffing scores had been decrease than donning scores throughout all contributors (65.8% vs 82.8%, p<0.001). Participant scores elevated 26.9% (95% CI of the distinction 24.7-29.1%, p<0.001) following our instructional intervention leading to all contributors assembly the MPS of 100%.

Conclusion: A mastery studying intervention with deliberate observe ensured the proper use of PPE by doctor topics in a simulated medical encounter of a COVID-19 affected person. Additional research of translational outcomes is required.

 

Multiplex detection of ctDNA mutations in plasma of colorectal most cancers sufferers by PCR/SERS assay 

Molecular diagnostic testing of KRAS and BRAF mutations has turn out to be crucial within the administration of colorectal most cancers (CRC) sufferers. Some progress has been made in liquid biopsy detection of mutations in circulating tumor DNA (ctDNA), which is a fraction of circulating cell-free DNA (cfDNA), however gradual evaluation for DNA sequencing strategies has restricted speedy diagnostics.

Different strategies reminiscent of quantitative PCR and extra lately, droplet digital PCR (ddPCR), have limitations in multiplexed capability and the necessity for costly specialised gear. Therefore, a sturdy, speedy and facile technique is required for detecting a number of ctDNA mutations to enhance the administration of CRC sufferers. To deal with this important drawback, herein, we suggest a brand new utility of multiplex PCR/SERS (surface-enhanced Raman scattering) assay for the detection of ctDNA in CRC, in a quick and non-invasive method to diagnose and stratify sufferers for efficient remedy.

Strategies: To discriminate ctDNA mutations from wild-type cfDNA, allele-specific primers had been designed for the amplification of three clinically necessary DNA level mutations in CRC together with KRAS G12V, KRAS G13D and BRAF V600E. Floor-enhanced Raman scattering (SERS) nanotags had been labelled with a brief and particular sequence of oligonucleotide, which may hybridize with the corresponding PCR amplicons. The PCR/SERS assay was applied by firstly amplifying the a number of mutations, adopted by binding with multicolor SERS nanotags particular to every mutation, and subsequent enrichment with magnetic beads. The mutation standing was evaluated utilizing a conveyable Raman spectrometer the place the fingerprint spectral peaks of the corresponding SERS nanotags point out the presence of the mutant targets. The tactic was then utilized to detect ctDNA from CRC sufferers beneath a blinded take a look at, the outcomes had been additional validated by ddPCR.

Outcomes: The PCR/SERS technique confirmed excessive specificity and sensitivity for genotyping CRC cell traces and plasma ctDNA, the place as few as 0.1% mutant alleles could possibly be detected from a background of plentiful wild-type cfDNA. The blinded take a look at utilizing 9 samples from superior CRC sufferers by PCR/SERS assay was validated with ddPCR and confirmed good consistency with pathology testing outcomes.

Conclusions: With ddPCR-like sensitivity but on the comfort of normal PCR, the proposed assay reveals nice potential in delicate detection of a number of ctDNA mutations for medical decision-making.

tumoritestacollo
tumoritestacollo

Anti-GPR151/Gpcr 2037 Antibody

A30814 100ul
EUR 476.4
Description: Rabbit Polyclonal GPR151/Gpcr 2037 Antibody. Validated in IF, WB and tested in Mouse, Rat.

Anti-GPR151/Gpcr 2037 Antibody

A14582 100ul
EUR 476.4
Description: Rabbit Polyclonal GPR151/Gpcr 2037 Antibody. Validated in WB and tested in Human, Mouse, Rat.

GPCR RDC1 Conjugated Antibody

C49041 100ul
EUR 476.4

GPCR GPR86 Conjugated Antibody

C48382 100ul
EUR 476.4

Anti-LGR6/Gpcr Lgr6 Antibody

A05990 100ul
EUR 476.4
Description: Rabbit Polyclonal LGR6/Gpcr Lgr6 Antibody. Validated in IHC and tested in Human, Mouse, Rat.

RTA-402

B1974-25 each
EUR 496.8

RTA-402

B1974-5 each
EUR 170.4

RTA-408

HY-12212 100mg
EUR 955.2

RTA 408

B2860-25 each
EUR 652.8

RTA 408

B2860-5 each
EUR 210

anti-5-oxo-ETE GPCR

YF-PA22585 50 ug
EUR 435.6
Description: Mouse polyclonal to 5-oxo-ETE GPCR

Omaveloxolone (RTA-408)

B3576-25 25 mg
EUR 637.2
Description: Omaveloxolone (RTA-408)

Omaveloxolone (RTA-408)

B3576-5 5 mg
EUR 247.2
Description: Omaveloxolone (RTA-408)

Rat GPCR ELISA Kit

ERG0026 96Tests
EUR 625.2

Goat GPCR ELISA Kit

EGTG0026 96Tests
EUR 625.2

Mouse GPCR ELISA Kit

EMG0026 96Tests
EUR 625.2

Sheep GPCR ELISA Kit

ESG0026 96Tests
EUR 625.2

Human GPCR ELISA Kit

EHG0026 96Tests
EUR 625.2

Monkey GPCR ELISA Kit

EMKG0026 96Tests
EUR 625.2

Rabbit GPCR ELISA Kit

ERTG0026 96Tests
EUR 625.2

Bovine GPCR ELISA Kit

EBG0026 96Tests
EUR 625.2

Canine GPCR ELISA Kit

ECG0026 96Tests
EUR 625.2

Porcine GPCR ELISA Kit

EPG0026 96Tests
EUR 625.2

Chicken GPCR ELISA Kit

ECKG0026 96Tests
EUR 625.2

Guinea Pig GPCR ELISA Kit

EGG0026 96Tests
EUR 625.2

DiscoveryProbe? GPCR Compound Library

L1025-.1 100 uL/well(10 mM solution)
EUR 5683.2

DiscoveryProbe? GPCR Compound Library

L1025-.25 250 uL/well(10 mM solution)
EUR 10221.6

DiscoveryProbe? GPCR Compound Library

L1025-5 5 mg/well
EUR 13284

Anserini GPCR-APJ ELISA Kit

EAG0026 96Tests
EUR 625.2

Orphan GPCR SP9155 Agonist P518 (human)

H-5984.0500 0.5mg
EUR 588
Description: Sum Formula: C127H195N37O37; CAS# [600171-68-4] net

Orphan GPCR SP9155 Agonist P518 (human)

H-5984.1000 1.0mg
EUR 1023.6
Description: Sum Formula: C127H195N37O37; CAS# [600171-68-4] net

Orphan GPCR SP9155 Agonist P550 (mouse)

H-5986.0500 0.5mg
EUR 588
Description: Sum Formula: C126H195N37O37; CAS# [600171-70-8] net

Orphan GPCR SP9155 Agonist P550 (mouse)

H-5986.1000 1.0mg
EUR 1023.6
Description: Sum Formula: C126H195N37O37; CAS# [600171-70-8] net

Anti-D-GPCR Antibody

A12058 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for D-GPCR Antibody (OR51E1) detection.tested for WB in Human.

Anti-D-GPCR antibody

STJ92705 200 µl
EUR 236.4
Description: Rabbit polyclonal to D-GPCR.

Anti-GPCR GPR3 Antibody

STJ501253 100 µg
EUR 571.2

Anti-GPCR GPR40 Antibody

STJ501005 100 µg
EUR 571.2

D-GPCR Polyclonal Antibody

ABP51168-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of D-GPCR from Human. This D-GPCR antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human D-GPCR at AA range: 210-290

D-GPCR Polyclonal Antibody

ABP51168-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of D-GPCR from Human. This D-GPCR antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human D-GPCR at AA range: 210-290

D-GPCR Polyclonal Antibody

ABP51168-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of D-GPCR from Human. This D-GPCR antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human D-GPCR at AA range: 210-290

D-GPCR Polyclonal Antibody

ES2167-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against D-GPCR from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA

D-GPCR Polyclonal Antibody

ES2167-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against D-GPCR from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA

DiscoveryProbe? GPCR/G protein-related Compounds Panel

L1009-5 5 mg/well
EUR 7242
Description: A wide range of well-characterized bioactive molecules that covers various targets related to GPCR, including adenosine receptor, adrenergic receptor and CXCR etc. Facilitate your research towards the insights of cancer, neurological disorders and heart diseases etc.

GPCR19 Antibody

47886-100ul 100ul
EUR 302.4

GPCR19 Antibody

20-abx121119
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Anti-GPCR GPR3 Antibody FITC

STJ501255 100 µg
EUR 703.2

Anti-GPCR LGR8/RXFP2 Antibody

A04848-1 100ug/vial
EUR 400.8

Anti-GPCR GPR40 Antibody FITC

STJ501007 100 µg
EUR 703.2

Anti-GPCR GPR7/NPBWR1 Antibody

A08247-1 100ug/vial
EUR 352.8

Anti-GPCR GPR40/FFAR1 Antibody

A01349-2 100ug/vial
EUR 352.8

Anti-GPCR GPR3 Antibody BIOTIN

STJ501254 100 µg
EUR 703.2

Anti-GPCR GPR40 Antibody BIOTIN

STJ501006 100 µg
EUR 703.2

GPCR5A antibody

70R-6472 50 ug
EUR 560.4
Description: Rabbit polyclonal GPCR5A antibody raised against the C terminal Of Gpcr5A

Cell Meterâ„¢ Beta-Arrestin Translocation GPCR Signaling Kit

36390-100Tests 100 Tests
EUR 781
Description: Virtually all G protein coupled receptors (GPCRs) rapidly undergo desensitization by a common pathway upon activation by ligand binding.

Cell Meterâ„¢ Beta-Arrestin Translocation GPCR Signaling Kit

36391-200Tests 200 Tests
EUR 989
Description: Virtually all G protein coupled receptors (GPCRs) rapidly undergo desensitization by a common pathway upon activation by ligand binding.

Polyclonal GPCR135 Antibody

AMM05178G 0.1ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCR135 . This antibody is tested and proven to work in the following applications:

Anti-GPR160/Gpcr150 Antibody

A14818 100ul
EUR 476.4
Description: Rabbit Polyclonal GPR160/Gpcr150 Antibody. Validated in WB and tested in Human.

G-Protein Coupled Receptor GPCR135 (GPCR135) Antibody

20-abx133555
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

Anti-GPR12/Gpcr12 Antibody

A10818 100ul
EUR 476.4
Description: Rabbit Polyclonal GPR12/Gpcr12 Antibody. Validated in IF and tested in Human.

GPCR19 Conjugated Antibody

C47886 100ul
EUR 476.4

Cell Meter™ Beta-Arrestin Translocation GPCR Signaling Kit

36390 100 Tests
EUR 781

Cell Meter™ Beta-Arrestin Translocation GPCR Signaling Kit

36391 200 Tests
EUR 989

Polyclonal GPCR6 / GPR101 Antibody (aa451-500)

APR16465G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCR6 / GPR101 (aa451-500). This antibody is tested and proven to work in the following applications:

Polyclonal GPCR6 / GPR101 Antibody (Cytoplasmic Domain)

APR16466G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCR6 / GPR101 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications:

Polyclonal GPCR6 / GPR101 Antibody (Cytoplasmic Domain)

APR16467G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCR6 / GPR101 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications:

Polyclonal GPCRW / GPR18 Antibody (Internal)

APC00054G 0.05ml
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCRW / GPR18 (Internal). This antibody is tested and proven to work in the following applications:

anti-GPCR 2037

YF-PA22241 50 ug
EUR 435.6
Description: Mouse polyclonal to Anti-GPCR 2037

anti-GPCR GPR3

YF-PA12103 50 ug
EUR 435.6
Description: Mouse polyclonal to GPCR GPR3

anti-GPCR C5L2

YF-PA18412 50 ug
EUR 435.6
Description: Mouse polyclonal to GPCR C5L2

anti-GPCR HM74

YF-PA15914 50 ug
EUR 435.6
Description: Mouse polyclonal to GPCR HM74

anti-GPCR EX33

YF-PA26233 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR EX33

anti-GPCR LGR7

YF-PA26522 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR LGR7

anti-GPCR LGR6

YF-PA26523 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR LGR6

anti-GPCR GPR3

YF-PA23809 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR GPR3

anti-GPCR GPR34

YF-PA12105 50 ug
EUR 435.6
Description: Mouse polyclonal to GPCR GPR34

anti-GPCR GPR62

YF-PA26842 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR GPR62

anti-GPCR SALPR

YF-PA18968 50 ul
EUR 435.6
Description: Mouse polyclonal to GPCR SALPR

anti-GPCR SALPR

YF-PA26165 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR SALPR

anti-GPCR MRGX2

YF-PA22009 50 ug
EUR 435.6
Description: Mouse polyclonal to Anti-GPCR MRGX2

anti-GPCR GPRC5D

YF-PA26334 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR GPRC5D

anti-GPCR TAS1R1

YF-PA26658 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR TAS1R1

anti-GPCR GPRC5D

YF-PA19735 50 ug
EUR 435.6
Description: Mouse polyclonal to GPCR GPRC5D

anti-GPCR GPR110

YF-PA22867 50 ul
EUR 435.6
Description: Mouse polyclonal to GPCR GPR110

anti-GPCR GPR110

YF-PA22868 50 ug
EUR 435.6
Description: Mouse polyclonal to GPCR GPR110

anti-GPCR GPR146

YF-PA21926 100 ug
EUR 483.6
Description: Rabbit polyclonal to Anti-GPCR GPR146

anti-GPCR LOC51210

YF-PA26875 50 ul
EUR 400.8
Description: Mouse polyclonal to GPCR LOC51210

anti-GPCR LOC51210

YF-PA22204 50 ul
EUR 435.6
Description: Mouse polyclonal to GPCR LOC51210

anti-GPCR LOC51210

YF-PA22205 50 ug
EUR 435.6
Description: Mouse polyclonal to GPCR LOC51210

anti-GPCR LOC51210

YF-PA22206 100 ul
EUR 483.6
Description: Rabbit polyclonal to GPCR LOC51210

anti-GPCR LOC51210

YF-PA22207 100 ug
EUR 483.6
Description: Rabbit polyclonal to GPCR LOC51210

Polyclonal GPCRW / GPR18 Antibody (Cytoplasmic Domain)

APR12199G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCRW / GPR18 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications:

Polyclonal GPCRW / GPR18 Antibody (Extracellular Domain)

APR12200G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCRW / GPR18 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

Polyclonal GPCRW / GPR18 Antibody (Extracellular Domain)

APR12201G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPCRW / GPR18 (Extracellular Domain). This antibody is tested and proven to work in the following applications:

Anti-GPCR EX33 (5C3)

YF-MA18601 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR EX33

Anti-GPCR EX33 (5B7)

YF-MA18602 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR EX33

Anti-GPCR EX33 (1D9)

YF-MA18603 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR EX33

Anti-GPCR LGR7 (3E3)

YF-MA11622 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR LGR7

Anti-GPCR GPR48 (8F6)

YF-MA18780 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR GPR48

Anti-GPCR SALPR (1F10)

YF-MA18467 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR SALPR

Anti-GPCR GPRC5D (6D9)

YF-MA18788 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR GPRC5D

Anti-GPCR LOC51210 (6D7)

YF-MA19845 100 ug
EUR 435.6
Description: Mouse monoclonal to GPCR LOC51210

MHC Class I RT1A (RT-1A) Antibody

abx415018-1mg 1 mg
EUR 994.8

MHC Class I RT1A (RT-1A) Antibody

abx415019-01mg 0.1 mg
EUR 526.8

MHC Class I RT1A (RT-1A) Antibody

abx415020-025mg 0.25 mg
EUR 678

MHC Class I RT1A (RT-1A) Antibody

abx415672-025mg 0.25 mg
EUR 678

MHC Class I RT1Ac (RT-1Ac) Antibody

abx413190-01mg 0.1 mg
EUR 526.8

MHC Class I RT1Ac (RT-1Ac) Antibody

abx413192-025mg 0.25 mg
EUR 678

MHC Class I RT1Ac (RT-1Ac) Antibody (RPE)

abx413191-100tests 100 tests
EUR 710.4

MHC Class I RT1Ac (RT-1Ac) Antibody (FITC)

abx413189-01mg 0.1 mg
EUR 610.8

Anti-T7 Antibody | RT7-45A

RT7-45A 1.0 mg
EUR 1142
Description:

Anti-T7 Antibody ; RT7-45A ; Immunology Consultants Laboratory

Host: Rabbit

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

GPC1 Antibody

43277-100ul 100ul
EUR 302.4

GPC5 Antibody

43675-100ul 100ul
EUR 302.4

GPC4 Antibody

43924-100ul 100ul
EUR 302.4

GPC2 Antibody

47512-100ul 100ul
EUR 302.4

GPC6 Antibody

47752-100ul 100ul
EUR 302.4

GPC1 antibody

70R-17557 50 ul
EUR 522
Description: Rabbit polyclonal GPC1 antibody

GPC3 antibody

70R-17558 50 ul
EUR 522
Description: Rabbit polyclonal GPC3 antibody

GPC4 antibody

70R-17559 50 ul
EUR 522
Description: Rabbit polyclonal GPC4 antibody

GPC5 antibody

70R-17560 50 ul
EUR 522
Description: Rabbit polyclonal GPC5 antibody

GPC3 antibody

70R-1567 100 ug
EUR 452.4
Description: Rabbit polyclonal GPC3 antibody raised against the middle region of GPC3

GPC4 antibody

10R-11432 100 ul
EUR 418.8
Description: Mouse Monoclonal GPC4 antibody

GPC4 antibody

10R-1168 100 ul
EUR 379.2
Description: Mouse monoclonal GPC4 antibody

GPC5 antibody

70R-51161 100 ul
EUR 292.8
Description: Purified Polyclonal GPC5 antibody

GPC5 Antibody

ABD4834 100 ug
EUR 525.6

GPC3 Antibody

ABD6710 100 ug
EUR 525.6

GPC3 Antibody

32513-100ul 100ul
EUR 302.4

GPC5 Antibody

35326-100ul 100ul
EUR 302.4

GPC5 Antibody

35326-50ul 50ul
EUR 224.4

GPC5 Antibody

1-CSB-PA008249
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GPC5. Recognizes GPC5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/40000

GPC3 Antibody

1-CSB-PA005135
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GPC3. Recognizes GPC3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000

GPC6 Antibody

1-CSB-PA929652
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against GPC6. Recognizes GPC6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200

GPC3 Antibody

DF6710 200ul
EUR 420

GPC5 Antibody

DF4834 200ul
EUR 420

GPC6 Antibody

1-CSB-PA169061
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against GPC6. Recognizes GPC6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:50-1:100

GPC6 Antibody

1-CSB-PA079476
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against GPC6. Recognizes GPC6 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

GPC3 Antibody

1-CSB-PA12749A0Rb
  • EUR 380.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against GPC3. Recognizes GPC3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IF; Recommended dilution: IF:1:50-1:200

GPC1 Antibody

1-CSB-PA009703GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GPC1. Recognizes GPC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

GPC1 Antibody

1-CSB-PA009703LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GPC1. Recognizes GPC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

GPC3 Antibody

1-CSB-PA009705GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GPC3. Recognizes GPC3 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

Gpc4 Antibody

1-CSB-PA009706EA01MO
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against Gpc4. Recognizes Gpc4 from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA

GPC4 Antibody

1-CSB-PA009706GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GPC4. Recognizes GPC4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

GPC4 Antibody

1-CSB-PA009706LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GPC4. Recognizes GPC4 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200, IF:1:50-1:200

GPC5 Antibody

1-CSB-PA009707GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GPC5. Recognizes GPC5 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

GPC6 Antibody

1-CSB-PA009708LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GPC6. Recognizes GPC6 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:200-1:500

GPC3 Antibody

F44195-0.08ML 0.08 ml
EUR 140.25
Description: Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants.

GPC3 Antibody

F44195-0.4ML 0.4 ml
EUR 322.15
Description: Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants.

GPC3 Antibody

F49601-0.4ML 0.4 ml
EUR 322.15
Description: GPC3 is a cell surface proteoglycan that bears heparan sulfate. This protein may be involved in the suppression/modulation of growth in the predominantly mesodermal tissues and organs, and may play a role in the modulation of IGF2 interactions with its receptor and thereby modulate its function. Members of the glypican-related integral membrane proteoglycan family contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol (GPI) linkage. These proteins may play a role in the control of cell division, growth regulation, and tumor predisposition. Deletion mutations in GPC3 are the cause of Simpson-Golabi-Behmel syndrome (SGBS), also known as Simpson dysmorphia syndrome (SDYS). SGBS is a condition characterized by pre- and postnatal overgrowth (gigantism) with visceral and skeletal anomalies.

Anti-T7 Antibody | RT7-45A-Z

RT7-45A-Z 0.1 mg
EUR 348
Description:

Anti-T7 Antibody ; RT7-45A-Z ; Immunology Consultants Laboratory

Host: Rabbit

Format: Unconjugated AP

Product Type: Primary Antibody

Antibody Clonality: Polyclonal

GPC6A antibody

70R-30938 100 ug
EUR 392.4
Description: Rabbit polyclonal GPC6A antibody

G6PC2 Antibody

20-abx313852
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

G6PC2 Antibody

1-CSB-PA873624LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against G6PC2. Recognizes G6PC2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

G6PC3 Antibody

DF13907 100ul
EUR 420

GPCR135 Blocking Peptide

20-abx061137
  • EUR 343.20
  • EUR 510.00
  • 1 mg
  • 5 mg

anti- G6PC3 antibody

FNab03268 100µg
EUR 702
Description: Antibody raised against G6PC3

G6PC2 Antibody (HRP)

20-abx313853
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GPC39 Polyclonal Antibody

ABP58680-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of GPC39 from Human. This GPC39 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPC39 protein at amino acid sequence of 120-200

GPC39 Polyclonal Antibody

ABP58680-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of GPC39 from Human. This GPC39 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPC39 protein at amino acid sequence of 120-200

GPC39 Polyclonal Antibody

ABP58680-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of GPC39 from Human. This GPC39 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GPC39 protein at amino acid sequence of 120-200

GPC39 Polyclonal Antibody

ES11734-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against GPC39 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

GPC39 Polyclonal Antibody

ES11734-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against GPC39 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

G6PC2 Antibody (FITC)

20-abx313854
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Glypican-3(GPC3/863) Antibody

BNC400863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), CF640R conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC400863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), CF640R conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC550863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), CF555 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC550863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), CF555 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC430863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), CF543 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC430863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), CF543 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC470863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), CF647 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC470863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), CF647 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC800863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), CF680 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC800863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), CF680 conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC810863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), CF680R conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC810863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), CF680R conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC610863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), CF660R conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNC610863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), CF660R conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNUM0863-50 50uL
EUR 474
Description: Primary antibody against Glypican-3(GPC3/863), 1mg/mL

Glypican-3(GPC3/863) Antibody

BNCB0863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), Biotin conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNCB0863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), Biotin conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNCP0863-250 250uL
EUR 459.6
Description: Primary antibody against Glypican-3(GPC3/863), PerCP conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNCAP0863-100 100uL
EUR 238.8
Description: Primary antibody against Glypican-3(GPC3/863), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNCAP0863-500 500uL
EUR 652.8
Description: Primary antibody against Glypican-3(GPC3/863), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Glypican-3(GPC3/863) Antibody

BNCA0863-250 250uL
EUR 459.6
Description: Primary antibody against Glypican-3(GPC3/863), APC conjugate, Concentration: 0.1mg/mL

Medical interns’ reflections on their coaching in use of private protecting gear

Background: The present COVID-19 pandemic has demonstrated that non-public protecting gear (PPE) is crucial, to forestall the acquisition and transmission of infectious ailments, but its use is usually sub-optimal within the medical setting.

Coaching and training are necessary to make sure and maintain the secure and efficient use of PPE by medical interns, however present strategies are sometimes insufficient in offering the related data and abilities. The aim of this research was to discover medical graduates’ experiences of using PPE and determine alternatives for enchancment in training and coaching programmes, to enhance occupational and affected person security.

Strategies: This research was undertaken in 2018 in a big tertiary-care instructing hospital in Sydney, Australia, to discover medical interns’ self-reported experiences of PPE use, firstly of their internship. Reflexive teams had been performed instantly after theoretical and sensible PPE coaching, throughout hospital orientation. Transcripts of recorded discussions had been analysed, utilizing a thematic method that drew on the COM-B (functionality, alternative, motivation – behaviour) framework for behaviour.

Outcomes: 80% of 90 eligible graduates participated. Many interns had not beforehand acquired formal coaching within the particular abilities required for optimum PPE use and had developed probably unsafe habits. Their experiences as medical college students in medical areas contrasted sharply with advisable observe taught at hospital orientation and impacted on their potential to domesticate appropriate PPE use.

Conclusions: Undergraduate instructing must be according to finest observe PPE use, and embody sensible coaching that embeds appropriate and secure practices.

, , , , , , , , , , , , , , , , , , , , , ,

Post navigation

Leave a Reply

Your email address will not be published. Required fields are marked *